Ascendis Pharma
(NASDAQ:ASND)
$133.13
-0.80[-0.60%]
At close: May 9
$133.13
0[0.00%]
After Hours: 4:00PM EDT
Q1 2024 Earnings were released on Thu May 2nd, after the market close
The most recent conference call was at 16:30 PM, 7 days ago Click to view past webcast
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Ascendis Pharma Stock (NASDAQ:ASND), Quotes and News Summary

Ascendis Pharma Stock (NASDAQ: ASND) stock price, news, charts, stock research, profile.

Open$134.800
Close$133.130
Volume / Avg.201.487K / 337.506K
Day Range132.800 - 134.800
52 Wk Range83.750 - 161.000
Market Cap$7.537B
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
37
Short Interest
9.16%
Days to Cover11.34

Recent News

These Five Small-Cap Stocks Under The Radar Are Expected To Surge, Says Stock Researcher
Ethan Meyers, the research director at Westfield Capital Management, has a knack for identifying promising investments that have proven fruitful, especially for the Harbor Small Cap Growth Fund, where Westfield is a subadviser.
Bibhu Pattnaik
Ascendis Pharma's Growth Hormone Deficiency Candidate Outperforms in Phase 3 Trial
Ascendis Pharma A/S (NASDAQ: ASND) released topline results from Phase 3 foresiGHt trial to compare the efficacy and safety of TransCon hGH (lonapegsomatropin) with placebo and daily hGH (human growth hormone, somatropin) in adults with growth 
Vandana Singh
Impact on BioMarin's Sentiment: Voxzogo's Triumph Clouded by Uncertainty
Raymond James initiated coverage on BioMarin Pharmaceuticals Inc (NASDAQ: BMRN) with a Market Perform rating, noting sparsity in 
Vandana Singh
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
4
Dec 23
3
Feb
1
Mar
3
1
Apr
3
May
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
3.5
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
ASND
LEGN

FAQ

Q

How do I buy Ascendis Pharma (ASND) stock?

A

You can purchase shares of Ascendis Pharma (NASDAQ: ASND) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Ascendis Pharma's (ASND) competitors?

A

Other companies in Ascendis Pharma’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).

Q

What is the target price for Ascendis Pharma (ASND) stock?

A

The latest price target for Ascendis Pharma (NASDAQ: ASND) was reported by Wells Fargo on Friday, May 3, 2024. The analyst firm set a price target for 262.00 expecting ASND to rise to within 12 months (a possible 96.80% upside). 34 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Ascendis Pharma (ASND)?

A

The stock price for Ascendis Pharma (NASDAQ: ASND) is $133.13 last updated Today at May 9, 2024 at 4:00 PM EDT.

Q

Does Ascendis Pharma (ASND) pay a dividend?

A

There are no upcoming dividends for Ascendis Pharma.

Q

When is Ascendis Pharma (NASDAQ:ASND) reporting earnings?

A

Ascendis Pharma’s Q1 earnings are confirmed for Thursday, May 2, 2024.

Q

Is Ascendis Pharma (ASND) going to split?

A

There is no upcoming split for Ascendis Pharma.

Q

What sector and industry does Ascendis Pharma (ASND) operate in?

A

Ascendis Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch